PharmaCyte Biotech Inc (PMCB)

[Triple9]

Over the last few months we learned plenty:

$PMCB won the 2017 Buzz of BIO “Pipelines of Promise” award at the BIO conferences, where over 16,000 pharma and bio employees from around the world heard the latest on CiaB's unique encapsulation technology.

Dr. Linda S. Sher, a professor at USC Keck Medical School, who has averaged 50-70 simultaneous clinical trials while at Keck, and who has been the principal or co-principal herself on over 50 clinical trials, has been appointed as $PMCB's Chief Medical Officer. If there is any IND delay, have you considered it's because Dr Sher has been providing invaluable insight and corrections to our IND submission?

Then we had Dr. Michael M. Abecassis added to the Board in July. Hum, maybe because some sort of corporate action required $PMCB to have a full board to vote.

In the 8K we learned that the master cell line was being made in the US in Pennsylvania, and not in Singapore/Thailand.

Finally, we have KW locking his Facebook account. Seems counter-intuitive that someone trying to hype his company would lock his Facebook account. Most logical answer is that he's signed a NDA.